First clinical cases of OXA-48-producing carbapenem-resistant Klebsiella pneumoniae in the United States: the "menace" arrives in the new world

OXA-48 has emerged as a major carbapenemase associated with the Enterobacteriaceae in Europe, North Africa, and Asia. We report the first two clinical cases of OXA-48-type carbapenemase-producing Enterobacteriaceae in the United States from patients recently hospitalized in Saudi Arabia and India. E...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical microbiology Jg. 51; H. 2; S. 680
Hauptverfasser:	Mathers, Amy J, Hazen, Kevin C, Carroll, Joanne, Yeh, Anthony J, Cox, Heather L, Bonomo, Robert A, Sifri, Costi D
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 01.02.2013
Schlagworte:	Anti-Bacterial Agents - pharmacology beta-Lactam Resistance - genetics beta-Lactamases - biosynthesis beta-Lactamases - genetics Female Humans Klebsiella Infections - diagnosis Klebsiella Infections - microbiology Klebsiella pneumoniae - classification Klebsiella pneumoniae - drug effects Klebsiella pneumoniae - genetics Microbial Sensitivity Tests Middle Aged Multilocus Sequence Typing United States United States
ISSN:	1098-660X, 1098-660X
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!